Literature DB >> 3060834

Plasma or serum in therapeutic drug monitoring and clinical toxicology.

D R Uges1.   

Abstract

The relative merits of plasma and serum in blood analysis are reviewed. The expression 'plasma concentration' is often used in the literature, although serum samples have been taken. In most cases serum and plasma concentrations of analytes are the same. The choice depends mostly on the policy of the hospital or the availability of the test tubes in the ward. Some of the advantages of plasma over serum are large volume, no delayed clotting, less risk of haemolysis. In addition, the sample is often suitable for both whole blood and plasma monitoring. Some of the disadvantages of plasma over serum are the (unknown) influence of the anticoagulant on the assay, on the protein binding and on the stability of the sample, the (unknown) influence of additives or impurities in the anticoagulants on the assay and on the concentration, the risk of the formation of small clots and dilution of the sample.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060834     DOI: 10.1007/bf01956868

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  17 in total

1.  Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients.

Authors:  M Linnoila; F Dorrity; K Jobson
Journal:  Am J Psychiatry       Date:  1978-05       Impact factor: 18.112

2.  Results for serum and plasma compared in 15 selected radioassays.

Authors:  N P Kubasik; H E Sine
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

3.  Vitamin B12-binding proteins in serum and plasma in various disorders. Effect of anticoagulants.

Authors:  R Carmel
Journal:  Am J Clin Pathol       Date:  1978-03       Impact factor: 2.493

4.  Zinc in plasma and serum: influence of contamination due to the collection tubes.

Authors:  J J Keyzer; E Oosting; B G Wolthers; F A Muskiet; F R Hindriks; W Van der Slik
Journal:  Pharm Weekbl Sci       Date:  1983-10-21

5.  Blood/plasma distribution ratios of psychotropic drugs.

Authors:  K P Maguire; G D Burrows; T R Norman; B A Scoggins
Journal:  Clin Chem       Date:  1980-10       Impact factor: 8.327

Review 6.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

7.  Interference of heparin containing benzyl alcohol in the fluorometric determination of plasma corticosteroids.

Authors:  E E Werk; K E Theiss; Y K Choi; R T Marnell
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

8.  Variability in heparin effect on serum drug binding.

Authors:  C A Naranjo; E M Sellers; V Khouw; P Alexander; T Fan; J Shaw
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

9.  Another physician's office analyzer: the Abbott "Vision" evaluated.

Authors:  J M Hicks; M Iosefsohn
Journal:  Clin Chem       Date:  1987-06       Impact factor: 8.327

10.  Heat inhibition of in vitro lipolysis and 14C ibuprofen protein binding in plasma from heparinized uraemic subjects.

Authors:  G A Pearce; K F Brown
Journal:  Life Sci       Date:  1983-10-10       Impact factor: 5.037

View more
  4 in total

1.  Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.

Authors:  Nhi Phung; Karen Kuncze; Hideaki Okochi; Alexander Louie; Leslie Z Benet; Igho Ofokotun; David W Haas; Judith S Currier; Tariro D Chawana; Anandi N Sheth; Peter Bacchetti; Monica Gandhi; Howard Horng
Journal:  Rapid Commun Mass Spectrom       Date:  2018-03-15       Impact factor: 2.419

2.  Exposure to Persistent Organic Pollutants (POPs) and Their Relationship to Hepatic Fat and Insulin Insensitivity among Asian Indian Immigrants in the United States.

Authors:  Michele A La Merrill; Caitlin L Johnson; Martyn T Smith; Namratha R Kandula; Anthony Macherone; Kurt D Pennell; Alka M Kanaya
Journal:  Environ Sci Technol       Date:  2019-11-20       Impact factor: 9.028

3.  Comparison of digoxin concentration in plastic serum tubes with clot activator and heparinized plasma tubes.

Authors:  Lora Dukić; Ana-Maria Simundić; Davorin Malogorski
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

4.  Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.

Authors:  Maria Garcia-Cremades; Belen P Solans; Emma Hughes; Jacqueline P Ernest; Erika Wallender; Francesca Aweeka; Anne F Luetkemeyer; Radojka M Savic
Journal:  Clin Pharmacol Ther       Date:  2020-05-12       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.